The CDK4/6 inhibitors Palbociclib and Abemaciclib have shown synergy with Menin inhibitors in KMT2A‐ und NUP98‐rearranged as well as NPM1‐mutated AML.108, 117, 118. This evidence concerns the gene NPM1 and acute myeloid leukemia.